Survivin as a Cancer Vaccine Target

Review Article - (2014) Volume 5, Issue 3

Michael J Ciesielski^1,²^*, Jingxin Qiu³ and Robert A Fenstermaker^1,⁴: ¹Department of Neurosurgery, Roswell Park Cancer Institute and State University of New York School of Medicine and Biomedical Sciences, Elm and Carlton Streets, Buffalo, New York, 14263, USA, E-mail: JingxinQiu@gmail.com; ²Department of Immunology, Roswell Park Cancer Institute and State University of New York School of Medicine and Biomedical Sciences, Elm and Carlton Streets, Buffalo, New York, 14263, USA, E-mail: JingxinQiu@gmail.com; ³Department of Pathology, Roswell Park Cancer Institute and State University of New York School of Medicine and Biomedical Sciences, Elm and Carlton Streets, Buffalo, New York, 14263, USA, E-mail: JingxinQiu@gmail.com; ⁴Center for Immunotherapy, Roswell Park Cancer Institute and State University of New York School of Medicine and Biomedical Sciences, Elm and Carlton Streets, Buffalo, New York, 14263, USA, E-mail: JingxinQiu@gmail.com

^*Corresponding Author: